This story has been updated from a previous version. 

NEW YORK, July 16 – PerkinElmer has agreed to acquire Packard BioScience in a stock deal valued at about $650 million.    

According to a statement released by the companies on Sunday, PerkinElmer seemed particularly interested in acquiring Packard BioScience for its liquid handling and sample preparation capabilities.    

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.